Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dianqing Sun

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Antimicrobial Agents and Chemotherapy|January 24, 2024
<i>In vivo</i> evaluation of <i>Clostridioides difficile</i> enoyl-ACP reductase II (FabK) inhibition by phenylimidazole unveils a promising narrow-spectrum antimicrobial strategyChetna Dureja, Jacob T Rutherford, Fahad B A Pavel, et al.
Biorxiv : the Preprint Server for Biology|October 4, 2023
<i>In vivo</i> evaluation of <i>Clostridioides difficile</i> enoyl-ACP reductase II (FabK) Inhibition by phenylimidazole unveils a promising narrow-spectrum antimicrobial strategyChetna Dureja, Jacob T Rutherford, Fahad B A Pavel, et al.
ACS Bio & Med Chem Au|February 23, 2026
Structural and Biochemical Characterization of <i>Fusobacterium nucleatum</i> Enoyl-ACP Reductase II (FabK) Reveals the Basis for Bacterial Species-Specific InhibitionKristiana Avad, Osama Alaidi, Destiny Okpomo, et al.
Bioorganic & Medicinal Chemistry Letters|October 17, 2007
Discovery of novel isoxazolines as anti-tuberculosis agentsRajendra P Tangallapally, Dianqing Sun, Rakesh, et al.
ACS Chemical Biology|June 12, 2019
Small-Molecule Inhibition of the <i>C. difficile</i> FAS-II Enzyme, FabK, Results in Selective ActivityJesse A Jones, Allan M Prior, Ravi K R Marreddy, et al.
ACS Infectious Diseases|December 4, 2018
The Fatty Acid Synthesis Protein Enoyl-ACP Reductase II (FabK) is a Target for Narrow-Spectrum Antibacterials for Clostridium difficile InfectionRavi K R Marreddy, Xiaoqian Wu, Madhab Sapkota, et al.
Bioorganic & Medicinal Chemistry|May 24, 2023
Synthesis and evaluation of phenylimidazole FabK inhibitors as new Anti-C. Difficile agentsKrissada Norseeda, Fahad Bin Aziz Pavel, Jacob T Rutherford, et al.
The Journal of Antibiotics|April 4, 2013
Syntheses and evaluation of macrocyclic engelhardione analogs as antitubercular and antibacterial agentsLi Shen, Marcus M Maddox, Sudip Adhikari, et al.
Bioorganic & Medicinal Chemistry Letters|September 8, 2015
Determination of the absolute configuration of chaetoviridins and other bioactive azaphilones from the endophytic fungus Chaetomium globosumUi Joung Youn, Tawanun Sripisut, Eun-Jung Park, et al.
ACS Combinatorial Science|February 13, 2018
Solid-Phase Synthesis and Antibacterial Activity of Cyclohexapeptide Wollamide B AnalogsLissa S Tsutsumi, John M Elmore, Uyen T Dang, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Antimicrobial Agents and Chemotherapy|January 24, 2024
<i>In vivo</i> evaluation of <i>Clostridioides difficile</i> enoyl-ACP reductase II (FabK) inhibition by phenylimidazole unveils a promising narrow-spectrum antimicrobial strategyChetna Dureja, Jacob T Rutherford, Fahad B A Pavel, et al.
Biorxiv : the Preprint Server for Biology|October 4, 2023
<i>In vivo</i> evaluation of <i>Clostridioides difficile</i> enoyl-ACP reductase II (FabK) Inhibition by phenylimidazole unveils a promising narrow-spectrum antimicrobial strategyChetna Dureja, Jacob T Rutherford, Fahad B A Pavel, et al.
ACS Bio & Med Chem Au|February 23, 2026
Structural and Biochemical Characterization of <i>Fusobacterium nucleatum</i> Enoyl-ACP Reductase II (FabK) Reveals the Basis for Bacterial Species-Specific InhibitionKristiana Avad, Osama Alaidi, Destiny Okpomo, et al.
Bioorganic & Medicinal Chemistry Letters|October 17, 2007
Discovery of novel isoxazolines as anti-tuberculosis agentsRajendra P Tangallapally, Dianqing Sun, Rakesh, et al.
ACS Chemical Biology|June 12, 2019
Small-Molecule Inhibition of the <i>C. difficile</i> FAS-II Enzyme, FabK, Results in Selective ActivityJesse A Jones, Allan M Prior, Ravi K R Marreddy, et al.
ACS Infectious Diseases|December 4, 2018
The Fatty Acid Synthesis Protein Enoyl-ACP Reductase II (FabK) is a Target for Narrow-Spectrum Antibacterials for Clostridium difficile InfectionRavi K R Marreddy, Xiaoqian Wu, Madhab Sapkota, et al.
Bioorganic & Medicinal Chemistry|May 24, 2023
Synthesis and evaluation of phenylimidazole FabK inhibitors as new Anti-C. Difficile agentsKrissada Norseeda, Fahad Bin Aziz Pavel, Jacob T Rutherford, et al.
The Journal of Antibiotics|April 4, 2013
Syntheses and evaluation of macrocyclic engelhardione analogs as antitubercular and antibacterial agentsLi Shen, Marcus M Maddox, Sudip Adhikari, et al.
Bioorganic & Medicinal Chemistry Letters|September 8, 2015
Determination of the absolute configuration of chaetoviridins and other bioactive azaphilones from the endophytic fungus Chaetomium globosumUi Joung Youn, Tawanun Sripisut, Eun-Jung Park, et al.
ACS Combinatorial Science|February 13, 2018
Solid-Phase Synthesis and Antibacterial Activity of Cyclohexapeptide Wollamide B AnalogsLissa S Tsutsumi, John M Elmore, Uyen T Dang, et al.
Pageof 5